As polyclonal cells, iTreg can be massively expanded from naïve CD4+T cells in vitro, and it is easy to obtain the number of cells in therapeutic doses, suggesting that iTreg based therapy is a good choice for the treatment of autoimmune diseases. The gene discussed is CD4; the disease is autoimmune disease.